Full Press Release Details
Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ - Friday, April 21, 2023: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM; SEHK:13) announces that the non-performance based awards granted under the Long Term Incentive Plan ("LTIP") on April 20, 2020 to the following persons discharging managerial responsibilities were vested on April 20, 2023:-
| Award Holder | Number of American depositary shares ("ADS") | |
| Mr Simon To (Executive Director) | 2,397 1 | |
| Dr Dan Eldar (Non-executive Director ("NED")) | 2,397 | |
| Ms Edith Shih (NED) | 2,397 2 | |
| Mr Paul Carter (Independent Non-executive Director ("INED")) | 2,037 3 | |
| Dr Karen Ferrante (INED) | 2,397 | |
| Mr Graeme Jack (INED) | 2,397 | |
| Professor Tony Mok (INED) | 2,397 |
The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.
| HIDDEN_ROW | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Dr Dan Eldar | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Non-Executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | HUTCHMED (China) Limited | ||||
| b) | LEI | 2138006X34YDQ6OBYE79 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument | ADS each representing five Ordinary Shares of US$0.10 | ||||
| Identification code | ADS ISIN: US44842L1035 | |||||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| Nil | 2,397 ADS | |||||
| d) | Aggregated information | N/A | ||||
| - Aggregated volume | ||||||
| - Price | ||||||
| e) | Date of the transaction | 2023-04-20 | ||||
| f) | Place of the transaction | Outside a trading venue |
| HIDDEN_ROW | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Mr Paul Carter | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Independent Non-Executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | HUTCHMED (China) Limited | ||||
| b) | LEI | 2138006X34YDQ6OBYE79 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument | ADS each representing five Ordinary Shares of US$0.10 | ||||
| Identification code | ADS ISIN: US44842L1035 | |||||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| Nil | 2,037 ADS | |||||
| d) | Aggregated information | N/A | ||||
| - Aggregated volume | ||||||
| - Price | ||||||
| e) | Date of the transaction | 2023-04-20 | ||||
| f) | Place of the transaction | Outside a trading venue |
(c) Dr Karen Ferrante
| HIDDEN_ROW | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Dr Karen Ferrante | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Independent Non-Executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | HUTCHMED (China) Limited | ||||
| b) | LEI | 2138006X34YDQ6OBYE79 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument | ADS each representing five Ordinary Shares of US$0.10 | ||||
| Identification code | ADS ISIN: US44842L1035 | |||||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| Nil | 2,397 ADS | |||||
| d) | Aggregated information | N/A | ||||
| - Aggregated volume | ||||||
| - Price | ||||||
| e) | Date of the transaction | 2023-04-20 | ||||
| f) | Place of the transaction | Outside a trading venue |
| HIDDEN_ROW | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Mr Graeme Jack | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Independent Non-Executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | HUTCHMED (China) Limited | ||||
| b) | LEI | 2138006X34YDQ6OBYE79 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument | ADS each representing five Ordinary Shares of US$0.10 | ||||
| Identification code | ADS ISIN: US44842L1035 | |||||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| Nil | 2,397 ADS | |||||
| d) | Aggregated information | N/A | ||||
| - Aggregated volume | ||||||
| - Price | ||||||
| e) | Date of the transaction | 2023-04-20 | ||||
| f) | Place of the transaction | Outside a trading venue |
(e) Professor Tony Mok
| HIDDEN_ROW | ||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Professor Tony Mok | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Independent Non-Executive Director | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | HUTCHMED (China) Limited | ||||
| b) | LEI | 2138006X34YDQ6OBYE79 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument | ADS each representing five Ordinary Shares of US$0.10 | ||||
| Identification code | ADS ISIN: US44842L1035 | |||||
| b) | Nature of the transaction | Vesting of awards granted on April 20, 2020 under HUTCHMED's LTIP | ||||
| c) | Price(s) and volume(s) | |||||
| Price(s) | Volume(s) | |||||
| Nil | 2,397 ADS | |||||
| d) | Aggregated information | N/A | ||||
| - Aggregated volume | ||||||
| - Price | ||||||
| e) | Date of the transaction | 2023-04-20 | ||||
| f) | Place of the transaction | Outside a trading venue |
| Investor Enquiries | |
| Mark Lee, Senior Vice President | +852 2121 8200 |
| Annie Cheng, Vice President | +1 (973) 306-4490 |
| Media Enquiries | |
| Americas - Brad Miles, Solebury Strategic Communications | +1 (917) 570 7340 (Mobile) / bmiles@soleburystrat.com |
| Europe - Ben Atwell / Alex Shaw, FTI Consulting | +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) HUTCHMED@fticonsulting.com |
| Asia - Zhou Yi, Brunswick | +852 9783 6894 (Mobile) / HUTCHMED@brunswickgroup.com |
| Nominated Advisor | |
| Atholl Tweedie / Freddy Crossley, Panmure Gordon | +44 (20) 7886 2500 |